DEMG — Deltex Medical Share Price
Last trade - 00:00- £2.37m
- £3.44m
- £1.78m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.72 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.33 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -21.05% | ||
| Return on Equity | -45.48% | ||
| Operating Margin | -59.23% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 4.26 | 2.4 | 2.26 | 2.48 | 1.78 | n/a | n/a | -18.55% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Deltex Medical Group Plc is a United Kingdom-based medical device company. The Company develops, manufactures and distributes a hemodynamic monitoring technology. The Company's TrueVue platform offers three monitoring technologies, such as Oesophageal Doppler Monitoring (ODM+), Pulse Pressure Waveform Analysis (PPWA) and High Definition Impedance CardioGraphy (HD-ICG). Its ODM+ is a fluid management and cardiac output monitoring technology to directly measure both flow and pressure in adults and pediatrics. HD-ICG provides continuous and sensitive measurements of cardiac output and other hemodynamic parameters. The system is stabilized using HD-Z signal filter technology. HD-ICG disposable electrodes are placed on the neck and chest. PPWA uses the researched pulse pressure wave algorithm, which is available to derive hemodynamic parameters, calibrated from the Doppler. Its applications include surgery, acute kidney injury, enhanced recovery, paediatric, and COVID-19 critical care.
Directors
- Nigel Keen NEC
- Andy Mears CEO (52)
- Natalie Wettler FID
- Timothy Irish NED (58)
- Julian Cazalet NID
- Christopher Jones NID (54)
- Mark Wippell NID (62)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 6th, 2000
- Public Since
- August 20th, 2001
- No. of Employees
- 37
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 1,896,025,700
- Address
- Terminus Road, CHICHESTER, PO19 8TX
- Web
- https://www.deltexmedical.com/
- Phone
- +44 1243774837
- Contact
- Natalie Wettler
- Auditors
- Cooper Parry Group Limited
Latest News for DEMG
Upcoming Events for DEMG
Deltex Medical Group PLC Annual Shareholders Meeting
Deltex Medical Group PLC Annual Shareholders Meeting
Half Year 2024 Deltex Medical Group PLC Earnings Release
Similar to DEMG
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Advanced Oncotherapy
London Stock Exchange
Angle
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 19:06 UTC, shares in Deltex Medical are trading at 0.13p. This share price information is delayed by 15 minutes.
Shares in Deltex Medical last closed at 0.13p and the price had moved by -88.64% over the past 365 days. In terms of relative price strength the Deltex Medical share price has underperformed the FTSE All Share Index by -88.83% over the past year.
The overall consensus recommendation for Deltex Medical is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Deltex Medical does not currently pay a dividend.
Deltex Medical does not currently pay a dividend.
Deltex Medical does not currently pay a dividend.
To buy shares in Deltex Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 0.13p, shares in Deltex Medical had a market capitalisation of £2.37m.
Here are the trading details for Deltex Medical:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: DEMG
Based on an overall assessment of its quality, value and momentum Deltex Medical is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Deltex Medical. Over the past six months, its share price has underperformed the FTSE All Share Index by -23.85%.
As of the last closing price of 0.13p, shares in Deltex Medical were trading -55.74% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Deltex Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 0.13p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Deltex Medical's management team is headed by:
- Nigel Keen - NEC
- Andy Mears - CEO
- Natalie Wettler - FID
- Timothy Irish - NED
- Julian Cazalet - NID
- Christopher Jones - NID
- Mark Wippell - NID